LOKELMA
Active substance: sodium zirconium cyclosilicate
POWDER, FOR SUSPENSION · SODIUM ZIRCONIUM CYCLOSILICATE 5 g/5g
United StatesActive
Marketing holder: AstraZeneca Pharmaceuticals LP
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- SODIUM ZIRCONIUM CYCLOSILICATE · 5 g/5g
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-c5d6-76ac-b7d4-22913c608bdb,01a12095-f672-73d9-87b9-11c1566e3111,01a12096-d89d-78cb-8d6c-6cbf37cc80ca,01a1209d-d914-766d-89e5-bd47ff3e0d74;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0310-1105
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0310-1105 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0310-1105 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0310-1105 · Verified 2026-10-09 · open in source